Evidence map›Paper›PMID 40560502›Full record

ReviewAnnals of surgical oncology2026

Consensus Guideline for the Management of Malignant Gastrointestinal Obstruction in Patients with Peritoneal Surface Malignancies.

Varun V Bansal, Elizabeth L Godfrey, Javid Sadjadi, Ricardo J Bello, Riom Kwakman, Andres A Abreu, Vignesh Vudatha, Brian K Sparkman, Devon C Freudenberger, David G Su and 14 more

Abstract readReview
PubMed Publisher
In one paragraph

Review in Annals of surgical oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

24 authors.

Varun V Bansal *Yale School of Medicine, New Haven, CT, USA.
Elizabeth L Godfrey *Yale School of Medicine, New Haven, CT, USA.
Javid SadjadiUniversity of New Mexico, Albuquerque, NM, USA.
Ricardo J BelloMedical College of Wisconsin, Milwaukee, WI, USA.
Riom KwakmanRoswell Park Cancer Institute, Buffalo, NY, USA.
Andres A AbreuUniversity of Texas Southwestern, Dallas, TX, USA.
Vignesh VudathaVirginia Commonwealth University School of Medicine, Richmond, VA, USA.
Brian K SparkmanVirginia Commonwealth University School of Medicine, Richmond, VA, USA.
Devon C FreudenbergerVirginia Commonwealth University School of Medicine, Richmond, VA, USA.
David G SuYale School of Medicine, New Haven, CT, USA.
Kiran K TuragaYale School of Medicine, New Haven, CT, USA. kiran.turaga@yale.edu.
Dejan MicicUniversity of Chicago, Chicago, IL, USA.
Monica MalecUniversity of Chicago, Chicago, IL, USA.
Sandy TunUniversity of Chicago, Chicago, IL, USA.
Blasé PoliteUniversity of Chicago, Chicago, IL, USA.
Laura A LambertUniversity of Utah, Salt Lake City, UT, USA.
Alissa GreenbaumUniversity of New Mexico, Albuquerque, NM, USA.
Craig G GundersonYale School of Medicine, New Haven, CT, USA.
Thomas J SmithJohns Hopkins University, Baltimore, MD, USA.
Kimberly E KopeckyUniversity of Alabama, Birmingham, AL, USA.
Benjamin D PowersUniversity of Maryland, Baltimore, MD, USA.
Ugwuji N MaduekweMedical College of Wisconsin, Milwaukee, WI, USA.
Erin P WardUniversity of Utah, Salt Lake City, UT, USA.
Peritoneal Surface Malignancies (PSM) Consortium Group

Funding

Yale Cancer Center Advanced Training Program for Physician-Scientists (YCC-ATPP)T32CA233414 · NCI · YALE UNIVERSITY · PI Eric P. Winer · 2019 to 2026
$3.2M
Training Program in Cancer Prevention and Control and Cancer Health Equity (CPC-CHE)T32CA093423 · NCI · VIRGINIA COMMONWEALTH UNIVERSITY · PI Bernard F Fuemmeler, Oxana G Palesh · 2018 to 2026
$3.0M
National Institute of Heath T32 CA093423-13NCI NIH HHS T32 CA093423NCI NIH HHS T32 CA233414
6 · The paper itself

Abstract

backgroundMalignant gastrointestinal obstruction (MGIO), a frequent complication of peritoneal surface malignancies (PSM), often portends a poor prognosis. The lack of high-quality evidence on optimal management strategies necessitated a national consensus to address this clinical problem.

methodsA clinical management pathway was designed through a Delphi consensus process with national experts in peritoneal disease. Two rounds of voting were conducted to assess agreement levels with pathway blocks. Supporting evidence regarding procedural interventions for MGIO underwent evaluation via a rapid literature review.

resultsOf 111 participants responding in the first round, 90 (81%) responded in the second round. Over 90% consensus was achieved in 4/6 and 6/6 pathway blocks during rounds I and II, respectively. Encouraging a multidisciplinary approach, the pathway emphasized early palliative care assessments and iterative goals of care evaluation throughout treatment. Management was delineated on the basis of obstruction acuity, and selection criteria for palliative-intent surgical interventions and stenting were elucidated. Studies demonstrated limited benefits for such interventions in patients with multifocal obstructions, poor performance status, and high-grade and/or high-burden PSMs. In these cases, a recommendation for supportive care or upper GI decompression tube placement was favored. The overall level of evidence was generally low-moderate in existing literature.

conclusionsGiven limited evidence, the consensus-driven pathway provides crucial clinical guidance for practitioners dealing with MGIO in patients with PSM. There is a need for high-quality prospective evidence in this domain.

Indexed as

Intestinal ObstructionPalliative CarePeritoneal NeoplasmsPractice Guidelines as TopicConsensusDelphi TechniqueHumansPrognosisCytoreductive surgical proceduresGuidelinesIntestinal obstructionPeritoneal neoplasmsPeritoneal surface malignancies

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.